Fas ligand fusion protein

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/19 (2006.01) A61K 38/19 (2006.01) C07K 1/107 (2006.01) C07K 14/52 (2006.01) C07K 14/705 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2232876

A protein comprising the human Fas Ligand protein (hFasL) or a truncated human Fas Ligand protein or a functionally equivalent variant thereof that retain the Fas receptor-binding and apoptosis-inducing properties of hFasL and, linked either directly or indirectly to its C-terminus, a glycophospholipid is useful in preventing or treating tissue or organ graft rejection.

Cette protéine comprend, d'une part, la protéine ligand humaine Fas ou une protéine ligand humaine Fas tronquée ou une variante de celle-ci, fonctionnellement équivalente, retenant les propriétés de hFasL, lesquelles consistent à fixer le récepteur de Fas et à induire l'apoptose, et liée soit directement soit indirectement à sa partie C-terminale, et d'autre part, un glycophospholipide. Cette protéine est utile pour prévenir ou traiter le rejet de greffe d'organe ou de tissu.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Fas ligand fusion protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fas ligand fusion protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fas ligand fusion protein will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1703604

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.